Tuesday, October 6, 2015         

 Print   Email   Most Popular   Save   Post   Retweet

Hawaii Biotech exits bankruptcy

By Kristen Consillio


Hawaii Biotech Inc. has emerged from Chapter 11 bankruptcy nearly a year after it sold its dengue fever vaccine research unit to pharmaceutical giant Merck & Co. 

The privately-held biotech company, which develops vaccines for infectious diseases, filed for Chapter 11 reorganization in December 2009 after a shareholder dispute blocked venture capital financing.

U.S. Bankruptcy Judge Robert Faris confirmed today the company's reorganization plan and the close of bankruptcy proceedings.

 Print   Email   Most Popular   Save   Post   Retweet

Latest News/Updates